 In the context of acute kidney injury, M-CSF has been implicated in promoting repair following injury, but also been described in an opposing role, driving proliferation of a pro-inflammatory macrophage phenotype.PD-0360324 and MCS110 are CSF1 inhibitors in clinical trials for some cancers.See also CSF1R inhibitors.